Cytokinetics Inc (CYTK)
48.96
+2.22
(+4.75%)
USD |
NASDAQ |
Dec 20, 16:00
48.92
-0.04
(-0.08%)
After-Hours: 20:00
Cytokinetics Shareholders Equity (Quarterly): -13.91M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Insmed Inc | 483.42M |
| Rezolute Inc | 113.44M |
| Ocugen Inc | 40.63M |
| Scholar Rock Holding Corp | 79.20M |
| Mirum Pharmaceuticals Inc | 232.02M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.436B |
| Total Liabilities (Quarterly) | 1.450B |
| Debt to Equity Ratio | -47.16 |
| Current Ratio | 9.276 |
| Net Debt Paydown Yield | -0.15% |